ISO/TS 5798:2022

In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods

Publication date:   Apr 19, 2022

General information

90.93   Standard confirmed   Feb 7, 2026

ISO

ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems

Technical Specification

11.100.01   Laboratory medicine in general

Buying

  Published

PDF - €219.01

  English   French  



Buy

Scope

This document provides requirements and recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.
This document is applicable to medical laboratories. It is also intended to be used by in vitro diagnostic developers and manufacturers, as well as by institutions and organizations supporting SARS-CoV-2 research and diagnostics.
This document does not apply to environmental samples.

Life cycle

NOW

PUBLISHED
ISO/TS 5798:2022
90.93 Standard confirmed
Feb 7, 2026